Cargando…
The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)
BACKGROUND: Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, pioneered by Grob for spondylolisthesis. The newly devel...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944216/ https://www.ncbi.nlm.nih.gov/pubmed/20819219 http://dx.doi.org/10.1186/1471-2474-11-199 |
_version_ | 1782187096477270016 |
---|---|
author | Birkenmaier, Christof Suess, Olaf Pfeiffer, Michael Burger, Ralf Schmieder, Kirsten Wegener, Bernd |
author_facet | Birkenmaier, Christof Suess, Olaf Pfeiffer, Michael Burger, Ralf Schmieder, Kirsten Wegener, Bernd |
author_sort | Birkenmaier, Christof |
collection | PubMed |
description | BACKGROUND: Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, pioneered by Grob for spondylolisthesis. The newly developed GO-LIF procedure expands the scope of the Grob technique in several important ways and adds security by means of robotic-assisted navigation. This is the first clinical trial on the GO-LIF procedure and it will assess safety and efficacy. METHODS/DESIGN: Multicentric prospective study with n = 40 patients to undergo single level instrumented spinal arthrodesis of the lumbar or the lumbosacral spine, based on a diagnosis of: painful disc degeneration, painful erosive osteochondrosis, segmental instability, recurrent disc herniation, spinal canal stenosis or foraminal stenosis. The primary target criteria with regards to safety are: The number, severity and cause of intra- and perioperative complications. The number of significant penetrations of the cortical layer of the vertebral body by the implant as recognized on postoperative CT. The primary target parameters with regards to feasibility are: Performance of the procedure according to the preoperative plan. The planned follow-up is 12 months and the following scores will be evaluated as secondary target parameters with regards to clinical improvement: VAS back pain, VAS leg pain, Oswestry Disability Index, short form - 12 health questionnaire and the Swiss spinal stenosis questionnaire for patients with spinal claudication. The secondary parameters with regards to construct stability are visible fusion or lack thereof and signs of implant loosening, implant migration or pseudarthrosis on plain and functional radiographs. DISCUSSION: This trial will for the first time assess the safety and efficacy of guided oblique lumbar interbody fusion. There is no control group, but the results, the outcome and the rate of any complications will be analyzed on the background of the literature on instrumented spinal fusion. Despite its limitations, we expect that this study will serve as the key step in deciding whether a direct comparative trial with another fusion technique is warranted. TRIAL REGISTRATION: Clinical Trials NCT00810433 |
format | Text |
id | pubmed-2944216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29442162010-09-24 The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF) Birkenmaier, Christof Suess, Olaf Pfeiffer, Michael Burger, Ralf Schmieder, Kirsten Wegener, Bernd BMC Musculoskelet Disord Study Protocol BACKGROUND: Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, pioneered by Grob for spondylolisthesis. The newly developed GO-LIF procedure expands the scope of the Grob technique in several important ways and adds security by means of robotic-assisted navigation. This is the first clinical trial on the GO-LIF procedure and it will assess safety and efficacy. METHODS/DESIGN: Multicentric prospective study with n = 40 patients to undergo single level instrumented spinal arthrodesis of the lumbar or the lumbosacral spine, based on a diagnosis of: painful disc degeneration, painful erosive osteochondrosis, segmental instability, recurrent disc herniation, spinal canal stenosis or foraminal stenosis. The primary target criteria with regards to safety are: The number, severity and cause of intra- and perioperative complications. The number of significant penetrations of the cortical layer of the vertebral body by the implant as recognized on postoperative CT. The primary target parameters with regards to feasibility are: Performance of the procedure according to the preoperative plan. The planned follow-up is 12 months and the following scores will be evaluated as secondary target parameters with regards to clinical improvement: VAS back pain, VAS leg pain, Oswestry Disability Index, short form - 12 health questionnaire and the Swiss spinal stenosis questionnaire for patients with spinal claudication. The secondary parameters with regards to construct stability are visible fusion or lack thereof and signs of implant loosening, implant migration or pseudarthrosis on plain and functional radiographs. DISCUSSION: This trial will for the first time assess the safety and efficacy of guided oblique lumbar interbody fusion. There is no control group, but the results, the outcome and the rate of any complications will be analyzed on the background of the literature on instrumented spinal fusion. Despite its limitations, we expect that this study will serve as the key step in deciding whether a direct comparative trial with another fusion technique is warranted. TRIAL REGISTRATION: Clinical Trials NCT00810433 BioMed Central 2010-09-06 /pmc/articles/PMC2944216/ /pubmed/20819219 http://dx.doi.org/10.1186/1471-2474-11-199 Text en Copyright ©2010 Birkenmaier et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Birkenmaier, Christof Suess, Olaf Pfeiffer, Michael Burger, Ralf Schmieder, Kirsten Wegener, Bernd The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF) |
title | The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF) |
title_full | The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF) |
title_fullStr | The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF) |
title_full_unstemmed | The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF) |
title_short | The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF) |
title_sort | european multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (go-lif) |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944216/ https://www.ncbi.nlm.nih.gov/pubmed/20819219 http://dx.doi.org/10.1186/1471-2474-11-199 |
work_keys_str_mv | AT birkenmaierchristof theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT suessolaf theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT pfeiffermichael theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT burgerralf theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT schmiederkirsten theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT wegenerbernd theeuropeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT birkenmaierchristof europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT suessolaf europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT pfeiffermichael europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT burgerralf europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT schmiederkirsten europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif AT wegenerbernd europeanmulticentertrialonthesafetyandefficacyofguidedobliquelumbarinterbodyfusiongolif |